Short Interest in NEXGEL, Inc. (NASDAQ:NXGL) Declines By 16.7%

NEXGEL, Inc. (NASDAQ:NXGL) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 13,000 shares, a drop of 16.7% from the August 31st total of 15,600 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 49,200 shares, the short-interest ratio is currently 0.3 days.

NEXGEL Price Performance

NEXGEL stock opened at $2.59 on Monday. The stock has a market cap of $16.13 million, a price-to-earnings ratio of -4.71 and a beta of 0.77. The company has a quick ratio of 0.81, a current ratio of 1.36 and a debt-to-equity ratio of 0.22. The business has a 50-day simple moving average of $2.74 and a 200 day simple moving average of $2.43. NEXGEL has a 52 week low of $1.46 and a 52 week high of $3.24.

NEXGEL (NASDAQ:NXGL) last released its quarterly earnings results on Monday, August 19th. The company reported ($0.14) EPS for the quarter. The company had revenue of $1.44 million during the quarter. NEXGEL had a negative return on equity of 64.21% and a negative net margin of 67.80%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NEXGEL stock. Northeast Financial Group Inc. bought a new position in NEXGEL, Inc. (NASDAQ:NXGL) during the first quarter, according to the company in its most recent filing with the SEC. The firm bought 11,848 shares of the company’s stock, valued at approximately $32,000. Northeast Financial Group Inc. owned 0.19% of NEXGEL as of its most recent SEC filing. 2.21% of the stock is owned by institutional investors.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.